Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process

This article was originally published in The Gray Sheet

Executive Summary

FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than a more extensive overhaul

You may also be interested in...



FDA Proposes Changes To Advisory Committee Voting Procedures

FDA is proposing that members of its advisory committees vote on issues simultaneously, rather than sequentially, to avoid influencing each other

FDA Proposes Changes To Advisory Committee Voting Procedures

FDA is proposing that members of its advisory committees vote on issues simultaneously, rather than sequentially, to avoid influencing each other

FDA Aims To Up Transparency By Making Panel Materials Public Sooner

FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a 1draft guidance released last week

Related Content

UsernamePublicRestriction

Register

MT023833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel